FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

Meet Executive Officer Dr. Julie Gralow

Jan 23, 2015 - This is the first in a periodic Front Line series profiling SWOG's Executive Officers, which I hope will give you some insight into why I selected each as a key member of my advisory team. This week I start with Dr. Julie Gralow, Executive Officer for breast, lung, and gynecologic cancers.

"Cancer is about living, not dying. I enjoy helping my breast cancer patients take control of their health through leading-edge treatments, education, exercise, nutrition, and a positive mental attitude." This statement of patient care philosophy, cribbed from Dr. Gralow's own Seattle Cancer Care Alliance (SCCA) profile page, is a great place to begin. Leading-edge treatments, education, exercise, and a positive attitude are key elements of her professional success as an oncologist and researcher.

Leading-edge treatments
Developing and refining the next generation of cancer treatments are, of course, SWOG's primary areas of focus -- and in the breast cancer research arena, Dr. Gralow's contributions are second to none. A SWOG member for almost 20 years now, she has been an author on more than 70 SWOG publications, has enrolled more than 150 patients to SWOG studies, and has been Study Chair or Study Co-Chair on eight of our clinical trials. Most notable among these may be the S0307 study, one of the largest treatment studies SWOG has ever led, which evaluated the use of bisphosphonates to reduce rates of recurrence in patients with breast cancer. Her extensive research/ leadership experience also includes 13 years as Vice-Chair of our Breast Committee.

Whether as a spokesperson for ASCO or an expert commentator on the PBS NewsHour, clips of Dr. Gralow presenting authoritative cancer information in her trademark clear, calm, upbeat manner are all over YouTube. She engages in this mission daily via social media, where the education goes both ways: she's been a pioneer in using Twitter to engage patients and advocates in the embryonic stages of clinical trial development. Even more personally relevent to my upcoming Kilimanjaro trip, she has educated me in the area of high-altitude mountaineering (!), having herself climbed that and many other serious peaks.

Clearly one to lead by example, Dr. Gralow serves as Team Physician and Medical Advisor -- as well as fellow adventurer -- to Team Survivor Northwest, which engages women cancer survivors in outdoor group activities such as mountaineering (see above), hiking, snowshoeing, triathlon training, and dragon boating (think extreme crew). She has also co-authored a book on breast cancer and exercise.

A positive attitude
Most illustrative in this category may be a short list of selected achievements that collectively go a very long way in helping cancer patients and their caregivers keep a positive attitude. Dr. Gralow has:

  • Co-founded a traveling exhibition of art by women who have faced breast cancer (still going strong after 18 years)
  • Led a group of SCCA clinical staff and breast-cancer survivors in editing a resource book of information for patients newly diagnosed with breast cancer
  • Founded the Women's Wellness Clinic at SCCA to promote the health of survivors of breast and gynecologic cancers, and of women at high risk for cancer
I could continue to list Dr. Gralow's accomplishments for a long time, but it's probably best I stop there; this post has passed the 500-word mark. The bar for our yet to be profiled Executive Officers has been set rather high!


SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified